MX3681A - Procedimiento para la produccion de gamma-carbolinas antipsicoticas y compuestos obtenidos. - Google Patents

Procedimiento para la produccion de gamma-carbolinas antipsicoticas y compuestos obtenidos.

Info

Publication number
MX3681A
MX3681A MX368186A MX368186A MX3681A MX 3681 A MX3681 A MX 3681A MX 368186 A MX368186 A MX 368186A MX 368186 A MX368186 A MX 368186A MX 3681 A MX3681 A MX 3681A
Authority
MX
Mexico
Prior art keywords
carbolins
antipsychotic
gamma
procedure
production
Prior art date
Application number
MX368186A
Other languages
English (en)
Inventor
Magid Abdel-Megid Abou-Gharbia
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of MX3681A publication Critical patent/MX3681A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MX368186A 1985-09-16 1986-09-08 Procedimiento para la produccion de gamma-carbolinas antipsicoticas y compuestos obtenidos. MX3681A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/776,180 US4636563A (en) 1985-09-16 1985-09-16 Antipsychotic γ-carbolines

Publications (1)

Publication Number Publication Date
MX3681A true MX3681A (es) 1993-10-01

Family

ID=25106686

Family Applications (1)

Application Number Title Priority Date Filing Date
MX368186A MX3681A (es) 1985-09-16 1986-09-08 Procedimiento para la produccion de gamma-carbolinas antipsicoticas y compuestos obtenidos.

Country Status (28)

Country Link
US (1) US4636563A (es)
EP (1) EP0223344B1 (es)
JP (1) JPS6267083A (es)
KR (1) KR900002245B1 (es)
CN (1) CN1013864B (es)
AR (1) AR242208A1 (es)
AT (1) ATE55770T1 (es)
AU (1) AU590605B2 (es)
CA (1) CA1275099A (es)
CY (1) CY1595A (es)
DE (1) DE3673607D1 (es)
DK (1) DK440686A (es)
EG (1) EG18015A (es)
ES (1) ES2002656A6 (es)
FI (1) FI83318C (es)
GB (1) GB2180536B (es)
GR (1) GR862343B (es)
HK (1) HK53491A (es)
HU (1) HU195217B (es)
IL (1) IL79956A0 (es)
MX (1) MX3681A (es)
NO (1) NO163619C (es)
NZ (1) NZ217580A (es)
PH (1) PH22515A (es)
PT (1) PT83344B (es)
SU (1) SU1442074A3 (es)
YU (1) YU45023B (es)
ZA (1) ZA866258B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5328905A (en) * 1987-07-20 1994-07-12 Duphar International Research B.V. 8,9-anellated-1,2,3,4-tetrahydro-β-carboline derivatives
US5360800A (en) * 1987-09-03 1994-11-01 Glaxo Group Limited Tetrahydro-1H-pyrido[4,3-b]indol-1-one derivatives
US4798896A (en) * 1988-01-19 1989-01-17 American Home Products Corporation Antipsychotic gamma-carboline N-oxides
HU207078B (en) * 1988-08-02 1993-03-01 Glaxo Group Ltd Process for producing lactam derivatives and pharmaceutical compositions comprising such compounds
JPH02167280A (ja) * 1988-08-15 1990-06-27 Glaxo Group Ltd ラクタム誘導体
US5021569A (en) * 1990-06-12 1991-06-04 American Home Products Corporation 4-azatricyclo[4.3.1.1(3,8)]undecylarylpiperazines with anxiolytic activity
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
FR2715659B1 (fr) * 1994-02-03 1996-03-22 Synthelabo Dérivés de 3-(2-aminoéthyl)-4-[3-(trifluorométhyl)benzoyl]-3,4-dihydro-2H-1,4-benzoxazine, leur préparation et leur application en thérapeutique.
CN1109880A (zh) * 1994-02-03 1995-10-11 合成实验室公司 3-(2-氨基乙基)-4-[3-(三氟甲基)苯甲酰基]-3，4-二氢-2h-1，4-苯并噁嗪衍生物、制备及其应用
JP3274579B2 (ja) * 1995-01-12 2002-04-15 住友製薬株式会社 脳血管障害に伴う精神症候治療剤
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
RU2106864C1 (ru) * 1995-10-23 1998-03-20 Николай Серафимович Зефиров Средство для лечения болезни альцгеймера
RU2283108C2 (ru) * 2003-12-08 2006-09-10 Сергей Олегович Бачурин ГЕРОПРОТЕКТОР НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО(4,3-b) ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ
US20070179174A1 (en) * 2003-12-08 2007-08-02 Bachurin Sergei O Methods and compositions for slowing aging
CA2617102A1 (en) * 2005-07-28 2007-02-08 Bristol-Myers Squibb Company Substituted tetrahydro-1h-pyrido[4,3,b]indoles as serotonin receptor agonists and antagonists
US20070117834A1 (en) * 2005-10-04 2007-05-24 David Hung Methods and compositions for treating Huntington's disease
RU2338537C2 (ru) * 2006-01-25 2008-11-20 Сергей Олегович Бачурин СРЕДСТВО ДЛЯ ЛЕЧЕНИЯ ШИЗОФРЕНИИ НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО(4,3-b)ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670010A1 (de) * 1966-12-07 1970-07-30 Abbott Lab Aroylalkylderivate von 1,2,3,4-Tetrahydro-5H-pyride-[4,3b]-indolen und Verfahren zur Herstellung derselben
US3522262A (en) * 1968-09-10 1970-07-28 Hoffmann La Roche 5-(pyridylalkyl)-pyridoindole derivatives
US3502688A (en) * 1968-09-10 1970-03-24 Hoffmann La Roche 5-(4-pyridylethyl)-pyridoindole derivatives
DE1952800C3 (de) * 1969-10-20 1974-04-18 Nautschno-Issledowatelskij Institut Farmakologii I Chimioterapii, Moskau 3,6-Dimethyl-l,2,3,4,4a,9a-hexahydro-gamma-carbolin-dihydrochlorid
US4001263A (en) * 1974-04-01 1977-01-04 Pfizer Inc. 5-Aryl-1,2,3,4-tetrahydro-γ-carbolines
DE2621729A1 (de) * 1976-05-15 1977-12-08 Boehringer Sohn Ingelheim Neue 2-(4-phenyl-4-cyanobutyl)-1,2, 3,4-tetrahydro-5(h)-pyrido- eckige klammer auf 4,3-b eckige klammer zu -indole und verfahren zu ihrer herstellung
US4224329A (en) * 1979-01-23 1980-09-23 Pfizer Inc. 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles
US4337250A (en) * 1979-07-30 1982-06-29 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4672117A (en) * 1985-09-16 1987-06-09 American Home Products Corporation Antipsychotic gamma-carbolines
PH25493A (en) * 1987-09-03 1991-07-24 Glaxo Group Ltd 2,3,4,5-tetrahydro-2-£(imidazol-(or-5)-yl)methyl-ih-pyrido£4,3-b|indol-1-ones , derivatives having 5-ht antagonist activity 3

Also Published As

Publication number Publication date
PT83344B (pt) 1988-07-29
SU1442074A3 (ru) 1988-11-30
US4636563A (en) 1987-01-13
AR242208A1 (es) 1994-08-31
KR870003103A (ko) 1987-04-15
HK53491A (en) 1991-07-19
FI83318B (fi) 1991-03-15
NO863671L (no) 1987-03-17
PH22515A (en) 1988-09-12
AU6181386A (en) 1987-03-19
ES2002656A6 (es) 1988-09-16
EG18015A (en) 1991-08-30
NO863671D0 (no) 1986-09-15
AU590605B2 (en) 1989-11-09
FI863692A0 (fi) 1986-09-12
CA1275099A (en) 1990-10-09
HU195217B (en) 1988-04-28
JPS6267083A (ja) 1987-03-26
GB8621226D0 (en) 1986-10-08
CN1013864B (zh) 1991-09-11
NO163619B (no) 1990-03-19
CY1595A (en) 1992-04-03
FI83318C (fi) 1991-06-25
YU157686A (en) 1988-04-30
GB2180536B (en) 1989-04-05
KR900002245B1 (ko) 1990-04-07
NZ217580A (en) 1988-07-28
YU45023B (en) 1991-06-30
ATE55770T1 (de) 1990-09-15
DE3673607D1 (en) 1990-09-27
EP0223344B1 (en) 1990-08-22
DK440686D0 (da) 1986-09-15
IL79956A0 (en) 1986-12-31
DK440686A (da) 1987-03-17
FI863692A (fi) 1987-03-17
EP0223344A1 (en) 1987-05-27
ZA866258B (en) 1988-04-27
GR862343B (en) 1987-01-12
NO163619C (no) 1990-06-27
HUT42478A (en) 1987-07-28
PT83344A (pt) 1986-10-01
CN86106194A (zh) 1987-03-18
GB2180536A (en) 1987-04-01

Similar Documents

Publication Publication Date Title
ES557723A0 (es) Procedimiento para la produccion de tiazoles
ES556927A0 (es) Procedimiento para la produccion de derivados de la 13-betamilbemicina
ES551924A0 (es) Procedimiento para la preracion de ester-2-(5-cloroquinolin-8-iloxi-5-acetico-alquilico.
ES540984A0 (es) Procedimiento para la produccion de imagenes
ES553084A0 (es) Procedimiento para la obtencion de acidos 7-amino-1-ciclopropil-6,8-dihalogeno-1,4-dihidro-4-oxo-3-quinolincarboxilico
IT1190018B (it) Procedimento per la produzione di beta-allumina
ES551071A0 (es) Procedimiento para la fabricacion de nuevos antibioticos de b-lactama
ES556313A0 (es) Procedimiento para la produccion de gamma-butirolactona.
ES556370A0 (es) Procedimiento para la obtencion de acidos 4-quinolon-3-carboxilicos 1,8-puenteados
ES544341A0 (es) Procedimiento para la obtencion de heteroariloxiacetamidas
MX3681A (es) Procedimiento para la produccion de gamma-carbolinas antipsicoticas y compuestos obtenidos.
ES555839A0 (es) Procedimiento para la obtencion de quinoloncarboxilatos.
ES557428A0 (es) Procedimiento para la fabricacion de derivados nucleosidos
ES552935A0 (es) Procedimiento para la produccion de d-l-amino acidos
ES554942A0 (es) Procedimiento para la obtencion de nuevos compuestos de piridazinio
ES557727A0 (es) Procedimiento para la obtencion de acidos 4-quinolon-3-carboxilicos 1,8-puenteados
ES553377A0 (es) Procedimiento para la produccion de 2,4,6-tris-(amino-fenilamino)-triacinas
ES552282A0 (es) Procedimiento para la obtencion de cefalosporinas
ES550351A0 (es) Procedimiento para la produccion de 8-alfa-acilamino-ergolinas.
ES553986A0 (es) Procedimiento para la obtencion de compuestos de heterociclil-penem
ES554606A0 (es) Procedimiento para la obtencion de piridiletil-dihidropiridinas
ES545451A0 (es) Procedimiento para la fabricacion de derivados de pirrolidi-na
ES549738A0 (es) Procedimiento para la produccion de derivados de 1,4-dihi- dropiridina
AR240944A1 (es) Procedimiento para la produccion de n -fosfonometilglicinas
ES554339A0 (es) Procedimiento para la obtencion de derivados de 1,4-dihidropiridina